David Colleran

Overview

David Colleran received an average of $2M in total compensation, including $388K in salary, at Anika Therapeutics between 2020 and 2021.

Source: SEC filings on April 27, 2022 and April 30, 2021.

Related executives

We found 13 more executives who work or worked at Anika Therapeutics.

Cheryl Blanchard

Anika Therapeutics

Chief Executive Officer

Michael Levitz

Anika Therapeutics

Chief Financial Officer

Thomas Finnerty

Anika Therapeutics

EVP, Human Resources

James Loerop

Anika Therapeutics

EVP, Business Development and Strategic Planning

Sylvia Cheung

Anika Therapeutics

Chief Financial Officer

Joseph Darling

Anika Therapeutics

Chief Executive Officer

Charles Sherwood

Anika Therapeutics

Chief Executive Officer

Edward Ahn

Anika Therapeutics

Chief Technology and Strategy Officer

News

You may also like